Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Combined With CURativE Intent Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. A Multicentre, Randomised, Open-label Phase-II Study

NCT06295094 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06295094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06295094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Combined With CURativE Intent Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. A Multicentre, Randomised, Open-label Phase-II Study
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
January 31, 2028
Enrollment
264 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, adjuvant, gastric cancer, minimally invasive surgical procedures, peritoneal metastases